BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17536016)

  • 1. Activation of mitogen-activated protein kinase kinase (MEK)/extracellular signal regulated kinase (ERK) signaling pathway is involved in myeloid lineage commitment.
    Hsu CL; Kikuchi K; Kondo M
    Blood; 2007 Sep; 110(5):1420-8. PubMed ID: 17536016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic effect of CCAAT enhancer-binding protein-alpha and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors.
    Hsu CL; King-Fleischman AG; Lai AY; Matsumoto Y; Weissman IL; Kondo M
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):672-7. PubMed ID: 16407117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling pathways implicated in hematopoietic progenitor cell proliferation and differentiation.
    Bugarski D; Krstic A; Mojsilovic S; Vlaski M; Petakov M; Jovcic G; Stojanovic N; Milenkovic P
    Exp Biol Med (Maywood); 2007 Jan; 232(1):156-63. PubMed ID: 17202596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor.
    Moon JJ; Nelson BH
    J Immunol; 2001 Sep; 167(5):2714-23. PubMed ID: 11509615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathway.
    Miranda MB; Xu H; Torchia JA; Johnson DE
    Leuk Res; 2005 Nov; 29(11):1293-306. PubMed ID: 16164983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of atypical protein kinase C in CSF-1-dependent Erk activation and proliferation in myeloid progenitors and macrophages.
    Lee AW
    PLoS One; 2011; 6(10):e25580. PubMed ID: 22028782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The membrane immunoglobulin receptor utilizes a Shc/Grb2/hSOS complex for activation of the mitogen-activated protein kinase cascade in a B-cell line.
    Kumar G; Wang S; Gupta S; Nel A
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):215-23. PubMed ID: 7717978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes.
    Boney CM; Gruppuso PA; Faris RA; Frackelton AR
    Mol Endocrinol; 2000 Jun; 14(6):805-13. PubMed ID: 10847583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p66shc inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells.
    Arany I; Faisal A; Nagamine Y; Safirstein RL
    J Biol Chem; 2008 Mar; 283(10):6110-7. PubMed ID: 18174162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion.
    Iwasaki-Arai J; Iwasaki H; Miyamoto T; Watanabe S; Akashi K
    J Exp Med; 2003 May; 197(10):1311-22. PubMed ID: 12756267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway.
    Purkerson JM; Parker DC
    J Immunol; 1998 Mar; 160(5):2121-9. PubMed ID: 9498749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoproterenol-induced beta-2 adrenergic receptor activation negatively regulates interleukin-2 signaling.
    Ruiz-Medina BE; Cadena-Medina DA; Esparza E; Arrieta AJ; Kirken RA
    Biochem J; 2018 Sep; 475(18):2907-2923. PubMed ID: 30120106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
    Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
    J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical role of c-Src and the Shc/Grb2/ERK2 signaling pathway in angiotensin II-dependent VSMC proliferation.
    Sayeski PP; Ali MS
    Exp Cell Res; 2003 Jul; 287(2):339-49. PubMed ID: 12837289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
    Gu J; Tamura M; Yamada KM
    J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential activation of T cell cytokine production by the extracellular signal-regulated kinase (ERK) signaling pathway.
    Egerton M; Fitzpatrick DR; Catling AD; Kelso A
    Eur J Immunol; 1996 Oct; 26(10):2279-85. PubMed ID: 8898934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling.
    Mood K; Saucier C; Ishimura A; Bong YS; Lee HS; Park M; Daar IO
    J Cell Physiol; 2006 Apr; 207(1):271-85. PubMed ID: 16331688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the molecular mechanisms underlying growth factor synergy: the role of ERK 2 activation in synergy.
    Pearson MA; O'Farrell AM; Dexter TM; Whetton AD; Owen-Lynch PJ; Heyworth CM
    Growth Factors; 1998; 15(4):293-306. PubMed ID: 9714913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.